Table 4.
Correlations of the changes of epicardial fat volume with markers for body composition and the markers for cardiometabolic risks in patients with type 2 diabetes
| r | p values | |
|---|---|---|
| Body weight (kg) | 0.710 | 0.032 |
| Body mass index (kg/m2) | 0.740 | 0.023 |
| Liver attenuation index | 0.233 | 0.546 |
| Visceral fat are (cm2) | 0.467 | 0.205 |
| Subcutaneous fat area (cm2) | 0.733 | 0.025 |
| Body fat (%) | 0.213 | 0.582 |
| Total fat mass (kg) | 0.260 | 0.500 |
| Total non-fat mass (kg) | 0.477 | 0.195 |
| Skeletal muscle index | 0.342 | 0.368 |
| HbA1c (%) | 0.341 | 0.370 |
| HOMA-IR | −0.383 | 0.308 |
| Triglycerides (mmol/l) | −0.067 | 0.865 |
| HDL cholesterol (mmol/l) | −0.395 | 0.292 |
| ALT (U/l) | −0.372 | 0.325 |
| Log C-reactive protein (mg/l) | −0.435 | 0.242 |
| Log ACR (mg/g) | 0.233 | 0.546 |
| Adiponectin (μg/ml) | 0.071 | 0.867 |
| Leptin (ng/ml) | −0.405 | 0.320 |
| Log interleukin 6 (pg/ml) | −0.262 | 0.531 |
ACR albumin-to-creatinine ratio, ALT alanine transaminase, HDL high-density lipoprotein, HOMA-IR homeostasis model assessment as an index of insulin resistance